Esflurbiprofen, also known as BTS-24332; SFPP; TT-063, is a cyclooxygenase (COX) inhibitor indicated for the treatment of osteoarthritis pain and inflammation. Price and Availability

Esflurbiprofen is not in stock, but may be available through custom synthesis. For cost-effective reason, minimum 1 gram order is requested. The product will be characterized by NMR, HPLC and MS analysis. Purity (HPLC) is usually 98%. CoA, QC data, MSDS will be provided when product is successfully made. The estimated lead time is 2-3 months. Please send email to sales@medkoo.com to inquire quote. BTS-24332; BTS 24332; BTS24332; TT-063; TT 063; TT063; SFPP; Esflurbiprofen. Trade name: Loqoa.IUPAC/Chemical Name: (S)-2-fluoro-α-methyl-4-biphenylacetic acidInChi Key: SYTBZMRGLBWNTM-JTQLQIEISA-NInChi Code: InChI=1S/C15H13FO2/c1-10(15(17)18)12-7-8-13(14(16)9-12)11-5-3-2-4-6-11/h2-10H,1H3,(H,17,18)/t10-/m0/s1SMILES Code: O=C(O)[C@@H](C)C1=CC=C(C2=CC=CC=C2)C(F)=C1 Technical Data Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs. Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

1: Calvo-Rodríguez M, García-Durillo M, Villalobos C, Núñez L. Aging Enables Ca2+ Overload and Apoptosis Induced by Amyloid-β Oligomers in Rat Hippocampal Neurons: Neuroprotection by Non-Steroidal Anti-Inflammatory Drugs and R-Flurbiprofen in Aging Neurons. J Alzheimers Dis. 2016 Jul 22;54(1):207-21. doi: 10.3233/JAD-151189. PubMed PMID: 27447424.

2: Cacciatore I, Marinelli L, Fornasari E, Cerasa LS, Eusepi P, Türkez H, Pomilio C, Reale M, D Angelo C, Costantini E, Di Stefano A. Novel NSAID-Derived Drugs for the Potential Treatment of Alzheimer s Disease. Int J Mol Sci. 2016 Jun 30;17(7). pii: E1035. doi: 10.3390/ijms17071035. PubMed PMID: 27376271; PubMed Central PMCID: PMC4964411.

3: Zhang Y, Wang X, Wang Q, Ge H, Tao L. Propofol depresses cisplatin cytotoxicity via the inhibition of gap junctions. Mol Med Rep. 2016 Jun;13(6):4715-20. doi: 10.3892/mmr.2016.5119. Epub 2016 Apr 13. PubMed PMID: 27082707.

4: Guo T, Li H, Wu L, Guo Z, Yin X, Wang C, Sun L, Shao Q, Gu J, York P, Zhang J. Prediction of Rate Constant for Supramolecular Systems with Multiconfigurations. J Phys Chem A. 2016 Feb 25;120(7):981-91. doi: 10.1021/acs.jpca.5b11816. Epub 2016 Feb 12. PubMed PMID: 26840799.

5: Song A, Zhang X, Li Y, Mao X, Han F. Effect of liquid-to-solid lipid ratio on characterizations of flurbiprofen-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) for transdermal administration. Drug Dev Ind Pharm. 2016 Aug;42(8):1308-14. doi: 10.3109/03639045.2015.1132226. Epub 2016 Jan 20. PubMed PMID: 26707734.

6: Kawase A, Yamamoto T, Egashira S, Iwaki M. Stereoselective Inhibition of Methotrexate Excretion by Glucuronides of Nonsteroidal Anti-inflammatory Drugs via Multidrug Resistance Proteins 2 and 4. J Pharmacol Exp Ther. 2016 Feb;356(2):366-74. doi: 10.1124/jpet.115.229104. Epub 2015 Dec 9. PubMed PMID: 26659924.

7: Sarkar S, Mondal KK, Roy SS, Gayen S, Ghosh A, De RR. Comparison of preoperative nepafenac (0.1%) and flurbiprofen (0.03%) eye drops in maintaining mydriasis during small incision cataract surgery in patients with senile cataract: A randomized, double-blind study. Indian J Pharmacol. 2015 Sep-Oct;47(5):491-5. doi: 10.4103/0253-7613.165201. PubMed PMID: 26600636; PubMed Central PMCID: PMC4621668.

8: Karlsson J, Morgillo CM, Deplano A, Smaldone G, Pedone E, Luque FJ, Svensson M, Novellino E, Congiu C, Onnis V, Catalanotti B, Fowler CJ. Interaction of the N-(3-Methylpyridin-2-yl)amide Derivatives of Flurbiprofen and Ibuprofen with FAAH: Enantiomeric Selectivity and Binding Mode. PLoS One. 2015 Nov 13;10(11):e0142711. doi: 10.1371/journal.pone.0142711. eCollection 2015. PubMed PMID: 26565710; PubMed Central PMCID: PMC4643906.

9: Gouveia-Figueira S, Karlsson J, Deplano A, Hashemian S, Svensson M, Fredriksson Sundbom M, Congiu C, Onnis V, Fowler CJ. Characterisation of (R)-2-(2-Fluorobiphenyl-4-yl)-N-(3-Methylpyridin-2-yl)Propanamide as a Dual Fatty Acid Amide Hydrolase: Cyclooxygenase Inhibitor. PLoS One. 2015 Sep 25;10(9):e0139212. doi: 10.1371/journal.pone.0139212. eCollection 2015. PubMed PMID: 26406890; PubMed Central PMCID: PMC4583449.

10: Agrawal R, Lee CS, Gonzalez-Lopez JJ, Khan S, Rodrigues V, Pavesio C. Flurbiprofen: A Nonselective Cyclooxygenase (COX) Inhibitor for Treatment of Noninfectious, Non-necrotizing Anterior Scleritis. Ocul Immunol Inflamm. 2016;24(1):35-42. doi: 10.3109/09273948.2015.1032308. Epub 2015 Aug 26. PubMed PMID: 26308394; PubMed Central PMCID: PMC4813454.

11: Li S, Wang X, Wang Y, Zhao Q, Zhang L, Yang X, Liu D, Pan W. A novel osmotic pump-based controlled delivery system consisting of pH-modulated solid dispersion for poorly soluble drug flurbiprofen: in vitro and in vivo evaluation. Drug Dev Ind Pharm. 2015;41(12):2089-99. doi: 10.3109/03639045.2015.1078348. Epub 2015 Aug 24. PubMed PMID: 26304493.

12: Chai XQ, Ma J, Xie YH, Wang D, Chen KZ. Flurbiprofen axetil increases arterial oxygen partial pressure by decreasing intrapulmonary shunt in patients undergoing one-lung ventilation. J Anesth. 2015 Dec;29(6):881-6. doi: 10.1007/s00540-015-2060-6. Epub 2015 Aug 14. PubMed PMID: 26272250.

13: Uehara S, Uno Y, Inoue T, Kawano M, Shimizu M, Toda A, Utoh M, Sasaki E, Yamazaki H. Novel Marmoset Cytochrome P450 2C19 in Livers Efficiently Metabolizes Human P450 2C9 and 2C19 Substrates, S-Warfarin, Tolbutamide, Flurbiprofen, and Omeprazole. Drug Metab Dispos. 2015 Oct;43(10):1408-16. doi: 10.1124/dmd.115.066100. Epub 2015 Jul 30. PubMed PMID: 26228688.

14: Chen Z, Zhang W, Wang L, Fan H, Wan Q, Wu X, Tang X, Tang JZ. Enantioseparation of Racemic Flurbiprofen by Aqueous Two-Phase Extraction With Binary Chiral Selectors of L-dioctyl Tartrate and L-tryptophan. Chirality. 2015 Sep;27(9):650-7. doi: 10.1002/chir.22481. Epub 2015 Jul 14. PubMed PMID: 26179618.

15: Tanino T, Funakami Y, Nagai N, Kato Y. Cyclosporin A-sensitive cytotoxicity of flurbiprofen non-stereoselectively mediated by cytochrome P450 metabolism in three-dimensional cultured rat hepatocytes. J Pharm Pharmacol. 2015 Oct;67(10):1406-15. doi: 10.1111/jphp.12443. Epub 2015 Jun 23. PubMed PMID: 26099455.

16: Mei C, Li B, Yin Q, Jin J, Xiong T, He W, Gao X, Xu R, Zhou P, Zheng H, Chen H. Liquid chromatography-tandem mass spectrometry for the quantification of flurbiprofen in human plasma and its application in a study of bioequivalence. J Chromatogr B Analyt Technol Biomed Life Sci. 2015 Jul 1;993-994:69-74. doi: 10.1016/j.jchromb.2015.04.037. Epub 2015 May 5. PubMed PMID: 25988430.

17: Roldán-Pijuán M, Pedersen-Bjergaard S, Gjelstad A. Parallel artificial liquid membrane extraction of acidic drugs from human plasma. Anal Bioanal Chem. 2015 Apr;407(10):2811-9. doi: 10.1007/s00216-015-8505-9. Epub 2015 Feb 15. PubMed PMID: 25682297.

18: Müllerová L, Dubský P, Gaš B. Generalized model of electromigration with 1:1 (analyte:selector) complexation stoichiometry: part II. Application to dual systems and experimental verification. J Chromatogr A. 2015 Mar 6;1384:147-54. doi: 10.1016/j.chroma.2015.01.055. Epub 2015 Jan 23. PubMed PMID: 25666498.

19: Gülcan HO, Ünlü S, Dimoglo A, Şahin Y, Esiringu İ, Erçetin T, Öz D, Şahin MF. Marginally designed new profen analogues have the potential to inhibit cyclooxygenase enzymes. Arch Pharm (Weinheim). 2015 Jan;348(1):55-61. doi: 10.1002/ardp.201400366. PubMed PMID: 25581679.

20: Siódmiak T, Mangelings D, Vander Heyden Y, Ziegler-Borowska M, Marszałł MP. High enantioselective Novozym 435-catalyzed esterification of (R,S)-flurbiprofen monitored with a chiral stationary phase. Appl Biochem Biotechnol. 2015 Mar;175(5):2769-85. doi: 10.1007/s12010-014-1455-4. Epub 2015 Jan 6. PubMed PMID: 25561056; PubMed Central PMCID: PMC4346682.